Citation: Mj. Gitlin, VENLAFAXINE, MONOAMINE-OXIDASE INHIBITORS, AND THE SEROTONIN SYNDROME, Journal of clinical psychopharmacology, 17(1), 1997, pp. 66-67
Citation: Mj. Gitlin et Ll. Altshuler, UNANSWERED QUESTIONS, UNKNOWN FUTURE FOR ONE OF OUR OLDEST MEDICATIONS, Archives of general psychiatry, 54(1), 1997, pp. 21-23
Citation: Mj. Gitlin, PSYCHOTROPIC MEDICATIONS AND THEIR EFFECTS ON SEXUAL FUNCTION - REPLY, The Journal of clinical psychiatry, 56(11), 1995, pp. 537-537
Citation: Kh. Nuechterlein et al., THE EARLY COURSE OF SCHIZOPHRENIA AND LONG-TERM MAINTENANCE NEUROLEPTIC THERAPY, Archives of general psychiatry, 52(3), 1995, pp. 203-205
Citation: Mj. Gitlin, PSYCHOTROPIC MEDICATIONS AND THEIR EFFECTS ON SEXUAL FUNCTION - DIAGNOSIS, BIOLOGY, AND TREATMENT APPROACHES, The Journal of clinical psychiatry, 55(9), 1994, pp. 406-413
Citation: Mj. Gitlin, PHARMACOTHERAPY OF PERSONALITY-DISORDERS - CONCEPTUAL-FRAMEWORK AND CLINICAL STRATEGIES, Journal of clinical psychopharmacology, 13(5), 1993, pp. 343-353